Jason is Team Director, Drug Product Development, Oral and Inhaled, GlaxoSmithKline.

Jason completed his undergraduate and post graduate education in Pharmacy at Kings College London. In 1997 he joined the SmithKline Beecham clinical manufacturing group where he built experience in the manufacture and release of oral and intravenous dose forms and since then has led several multidisciplinary teams in the development, registration and launch of IV and OSD products across the GSK portfolio. This has included assignments in medicine and process delivery, cell and gene therapy and more recently in process engineering and analytics focussed on platform modernisation and alignment.